Patent details

EP1243263 Title: Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain

Basic Information

Publication number:
EP1243263
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP011070265
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
French Title of Invention:
Nouvelle utilisation d'une classe de composés peptidiques pour le traitement de l'allodynie ou d'autres types de douleurs chroniques ou fantômes
German Title of Invention:
Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
SPC Number:

Dates

Filing date:
21/03/2001
Grant date:
27/11/2002
EP Publication Date:
27/11/2002
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/09/2002
EP B1 Publication Date:
27/11/2002
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/03/2012
Expiration date:
21/03/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/10/2010
 
 

Name:
UCB PHARMA GMBH
Address:
ALFRED NOBEL STRASSE 10, 40789, MONHEIM, Germany (DE)

History of Owners

From:
21/03/2001
To:
26/10/2010

Name:
SCHWARZ PHARMA AG
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/12/2002
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Selve Norma, Dr.
Address:
Germany (DE)

Classification

Main IPC Class:
A61K 31/165;
Filing date Document type Number of pages